Table 5.
3-month post-intervention outcomes: quality of life-HIV specific symptoms: general health assessment for children HIV symptoms. Percentage of adolescents reporting moderately, very much or extremely distressed by symptom at 3-month post-intervention controlling for baseline levels of symptoms
| HIV specific symptoms | FACE intervention n = 20 |
HLC comparison n = 18 |
P value |
|---|---|---|---|
| Physical/bodily pain | 5% | 0% | 0.210 |
| Coughing/Wheezing | 10% | 0% | 0.604 |
| Nausea/vomiting | 5% | 0% | 0.737 |
| Skin problems (rash, itching, etc) | 5% | 0% | 0.063+ |
| Fatigue | 0% | 5% | 0.095+ |
| Feeling dizzy/lightheaded | 5% | 0% | 0.178 |
| Fever/night sweats/shaking/chills | 5% | 0% | 0.737 |
| Loss of appetite | 5% | 0% | 0.663 |
| Trouble sleeping | 0% | 0% | 0.058+ |
| Eye trouble/problems with vision | 0% | 5% | 0.734 |
| Headaches | 5% | 0% | 0.342 |
| Dry or painful mouth/trouble swallowing | 0% | 0% | 1.0 |
| Chest pain or tightness | 5% | 0% | 1.0 |
| Difficulty breathing or catching breath | 0% | 0% | 0.656 |
| Runny nose/sinus trouble | 10% | 0% | 0.479 |
| Muscle aches/joint or bone pain | 0% | 0% | 0.232 |
| Pain, numbness or tingling | 0% | 0% | 0.792 |
| Overall discomfort | 0% | 0% | 0.697 |
+
Notes: All P values control for baseline using a t-test to assess significance at the 0.05 level.
Abbreviations: FACE, Family Centered Advance Care planning; EOL, end-of-life; HIV/AIDS, human immunodeficiency virus/acquired immune deficiency syndrome; HLC, healthy living control.